Codexis in agreement to use its ECO Synthesis platform for stereo-defined siRNA fragment manufacturing.
Codexis announces a new agreement with a pioneering siRNA drug innovator to use its ECO Synthesis platform for stereo-defined siRNA fragment manufacturing.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.